Form 4: Ingevity Director Receives Equity Grant

Ingevity Corporation director Francis David Segal was granted 1,904 restricted stock units as part of the company's 2025 Omnibus Incentive Plan.

Summary

• Director Francis David Segal acquired 1,904 shares of Ingevity Corporation common stock.
• The acquisition was in the form of a restricted stock unit grant.
• The transaction occurred on April 30, 2026.
• Following this transaction, the director's total beneficial ownership is 8,284 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on company operations or financial health.

Positives

• The grant aligns the director's interests with those of shareholders through equity ownership.

Negatives

• None identified.

Risks

• The value of the granted equity is subject to market fluctuations in Ingevity Corporation's stock price.

Future Outlook

The restricted stock units are scheduled to vest in full on April 30, 2027.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to ensure long-term alignment between board members and shareholders.

Comparison to Industry Standards

• The use of restricted stock units as a component of director compensation is consistent with standard practices for publicly traded companies in the specialty chemicals sector.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation practices.

Next Steps

• Vesting of the 1,904 restricted stock units on April 30, 2027.

Key Dates

Keywords

Ingevity, NGVT, Form 4, Insider Trading, Equity Grant, Director Compensation